← Back

China Reform Health Management and Services Group Co Ltd

China Reform Health Management and Services Group Co., Ltd. offers medical insurance management services in China. It provides services of medical insurance funds, medical quality and safety, drug and device supervision, and internet health protection. It is also involved in the pharmaceutical and medical business. China Reform Health Management and Services Group Co., Ltd. was formerly known as SeaRainbow Holding Corp. and changed its name to China Reform Health Management and Services Group Co., Ltd. in May 2018. The company was founded in 1987 and is based in Beijing, China.

Price · split & dividend adjusted
News & notes moving 000503.CS
000503.CS▼

Guoxin Health's 2026 interim report shows net loss of 102 million yuan, widening year-on-year

Guoxin Health released its 2026 interim report. Total operating revenue was 102 million yuan, up 6.30% year-on-year, but net profit attributable to the parent company was negative 102 million yuan, with the loss widening year-on-year, down 3.1783 million yuan compared with the same period last year. Net cash flow from operating activities was negative 137 million yuan, down 17.1598 million yuan year-on-year. The company's asset-liability ratio was 32.98%, gross margin was negative 14.57%, return on equity was negative 9.15%, and diluted earnings per share was negative 0.10 yuan. The number of shareholders was 59,200, and the top ten shareholders held 31.78% of the total share capital.
000503.CS ▼
Jiemian·1dRead more ▾
000503.CS▲

A-share pharmaceutical sector surges in afternoon trading, Guoxin Health and others hit daily limit up

Today, the pharmaceutical sector in the A-share market was active, with the DRG/DIP sub-sector leading gains. ST Rongke hit the 20 percent daily limit up, while Inspur Software, Saili Medical, and Guoxin Health also reached their daily limit up. In terms of news, the National Administration of Traditional Chinese Medicine and 10 other departments jointly issued the Action Plan for the Traditional Chinese Medicine Component of the Medical and Health Foundation Strengthening Project, aiming to enhance the supply of traditional Chinese medicine services at the grassroots level. About one minute after the afternoon session opened, Guoxin Health surged straight to its daily limit up, with its stock price reaching 7.17 yuan per share and its latest market capitalization at 7.021 billion yuan. Guoxin Health primarily engages in comprehensive medical insurance management services, offering DRG, DIP, and other diversified payment method services to medical insurance clients, and leveraging AI technology to provide solutions for medical institutions and disease control departments.
000503.CS ▲600756.CG ▲603716.CG ▲
市场行情·30dRead more ▾
000503.CS▼

Guoxin Health expects a loss of 103 million yuan in the first half of 2026

Guoxin Health disclosed its earnings forecast, expecting a net loss attributable to the parent company of 103 million yuan in the first half of 2026, compared with a loss of 99.09 million yuan in the same period last year. The company expects to achieve operating revenue of 102 million yuan in the same period, with a net loss after deducting non-recurring items of 103 million yuan, and basic earnings per share of negative 0.1054 yuan. The change in performance is mainly due to the seasonal characteristic of the business being lower in the first half and higher in the second half. The company is advancing AI empowerment and business upgrades around health and medical big data.
000503.CS ▼
中国证券报·44dRead more ▾
© 2026 MarketDXAsset